Product Information
TAMOXIFEN 20 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2834 per EA under NDC 00378027493. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
20 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378027493
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TAMOXIFEN CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA074732On Market Since
2/20/2003
Pharmacological Classes
Price Statistics
The NADAC for TAMOXIFEN 20 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2834 per EA |
|---|---|
| All-time high | $0.6125 (Aug 12, 2015) |
| All-time low | $0.2079 (Nov 20, 2024) |
| 52-week high | $0.3485 |
| 52-week low | $0.2792 |
| Median price | $0.4538 |
| Average price | $0.4382 |
| Largest weekly change | +45.1% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TAMOXIFEN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TAMOXIFEN 20 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2834 per EA (NDC 00378027493), effective Jun 24, 2026.
How has the price of TAMOXIFEN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for TAMOXIFEN 20 MG TABLET has declined 26.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMOXIFEN 20 MG TABLET?
Since Nov 28, 2013, the NADAC for TAMOXIFEN 20 MG TABLET has ranged from a low of $0.2079 (Nov 20, 2024) to a high of $0.6125 (Aug 12, 2015), with a median of $0.4538 per EA.
Are there cheaper alternatives to TAMOXIFEN 20 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as TAMOXIFEN 20 MG TABLET, but none are currently priced below it.
Who manufactures TAMOXIFEN 20 MG TABLET?
TAMOXIFEN 20 MG TABLET (NDC 00378027493) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification